other material
confidence high
sentiment positive
materiality 0.55
CervoMed receives US patent allowance for neflamapimod in dementia with Lewy bodies
CervoMed Inc.
- USPTO notice of allowance for patent covering neflamapimod for dementia with Lewy bodies in patients without substantial Alzheimer's tau pathology.
- Expected to provide intellectual property protection into 2042, excluding potential patent term extension.
- Patent protects use of drug candidate neflamapimod for this specific patient population.